Gadolinium—ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent: Kinetic and enhancement patterns in normal and cholestatic rats

Investigative Radiology

Volumn 27, Issue 8, 1992, Pages 612-619

  ClÉment, Olivier ^a   MÜhler, Andreas ^a   Vexler, Vladimir ^a   BerthezÈne, Yves ^a   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast enhancement; Contrast media; Gadolinium; Liver; Magnetic resonance experimental; Magnetic resonance stu7dies

Indexed keywords

BILIRUBIN; BROMSULFOPHTHALEIN; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; TAUROCHOLIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANION TRANSPORT; ARTICLE; BILE FLOW; BILIARY EXCRETION; CHOLESTASIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG ELIMINATION; DRUG UPTAKE; FEMALE; HEPATOBILIARY SYSTEM EXAMINATION; KIDNEY CLEARANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT;

ANIMAL; CHOLESTASIS; COMPARATIVE STUDY; CONTRAST MEDIA; DRUG EVALUATION, PRECLINICAL; FEMALE; GADOLINIUM; GADOLINIUM DTPA; LIVER; MAGNETIC RESONANCE IMAGING; METABOLIC CLEARANCE RATE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026712825     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/00004424-199208000-00010     Document Type: Article

References (31)

1. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic métastasés: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 1990;155:763-770.
2. Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferrucci JT. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 1990; 174:361-366.
3. Marchai G, van Hecke P, Demaerel P, et al. Detection of liver métastasés with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 1989;152:771-775.
4. Tsang YM, Stark DD, Chen MC, Weissleder R, Wittenberg J, Ferrucci JT. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging. Radiology 1988;167:21-24.
5. Weissleder R, Saini S, Stark DD, Wittenberg J, Ferrucci JT. Dual contrast MR imaging of liver cancer in rats. AJR 1988; 150:561-566.
6. Nelson RC, Umpierrez ME, Chezmar JL, Bernardino ME. Delayed magnetic resonance hepatic imaging with gadolinium-DTPA. Invest Radiol 1988;23:509-511.
7. Marchai G, Demaerel P, Decrop E, Van HP, Baert AL. Gadolinium-DOTA enhanced fast imaging of liver tumors at 1.5 T. J Comput Assist Tomogr 1990;14:217-222.
8. Schmiedl U, Kolbel G, Hess CF, Klose U, Kurtz B. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T. J Comput Assist Tomogr 1990;14:600-607.
9. Saini S, Stark DD, Brady TJ, Wittenberg J, Ferrucci JT. Dynamic spin-echo MRI of liver cancer using gadolinium-DTPA: animal investigation. AJR 1986;147:357-362.
10. Edelman RR, Siegel JB, Singer A, Dupuis K, Longmaid HE. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical Results. AJR 1989;153:1213-1219.
11. Edelman RR, Wallner B, Singer A, Atkinson DJ, Saini S. Segmented turboFLASH: method for breath-hold MR imaging of the liver with flexible contrast. Radiology 1990;177:515-521.
12. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
13. Mathieu D, Rahmouni A, Anglade MC, et al. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced turboflash MR imaging. Radiology 1991;180:25-30.
14. Lauffer RB, Vincent AC, Padmanabhan S, et al. Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivatives. Magn Reson Med 1987;4:582-590.
15. Hoener B-A, Engelstad BL, Ramos EC, et al. Comparison of Fe HBED and Fe-EHPG as hepatobiliary MR contrast agents. J Magn Reson Imaging 1991;1:357-362.
16. Shtem F, Garrido L, Compton C, Swiniarski JK, Lauffer RB, Brady TJ. MR imaging of blood-borne liver métastasés in mice: contrast enhancement with Fe-EHPG. Radiology 1991;178:83-89.
17. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnD PDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991;178:73-78.
18. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC. Hepatobiliary MR imaging: first human experience with MnD-PDP. Radiology 1991;178:79-82.
19. Young SW, Simpson BB, Rainer AV, Matkin C, Carter EA. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate. Magn Reson Med 1989;10:1-13.
20. Young SW, Bradley B, Muller HH, Rubin DL. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn Reson Imaging 1990;8:267-276.
21. Vittadini G, Felder E, Tirone P, Lorusso V. B-19036, a potential new hepatobiliary contrast agent for MR proton imaging. Invest Radiol 1988;23:S24-S248.
22. Vittadini G, Felder E, Musu C, Tirone P. Preclinical profile of Gd BOPTA: a liver-specific MRI contrast agent. Invest Radiol 1990; 25:S59-S60.
23. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology 1990;176:61-64.
24. Cavagna F, Tirone P, Felder E, de Haen C. Hepatobiliary contrast agents for magnetic resonance imaging. In: Ferrucci JT, Stark DD, eds. Liver imaging. Current trends and new techniques. Stoneham/ MA: Andover Medical; 1991:384-393.
25. Cavagna F, Tirone P, Felder E, de Haen C. Gd-BOPTA/ dimeglumine, a new hepatobiliary contrast agent for magnetic resonance imaging. Proceedings of the European Workshop on Magnetic Resonance in Medicine. 1990;83-94.
26. Weinmann H-J, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991; 22:233-237.
27. Klaassen CD, Watkins JB. Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharm Rev 1984;36:1-67.
28. Hamm B, Wolf KJ, Felix R. Conventional and rapid MR imaging of the liver with Gd-DTPA. Radiology 1987;164:313-320.
29. Schuhmann-Giampieri G, Schmitt-Willich H, Press W-R, Negishi C, Weinmann H-J, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a hepatobiliary contrast agent for MRI. Radiology 1992;183:53-58.
30. Moseley RH. Mechanisms of bile formation and cholestasis: clinical significance of recent experimental work. Am J Gastroenterol 1986;81:731-735.
31. Kaplowitz N. Physiological significance of glutathione-S-transferases. Editorial review. Am J Physiol 1980;239:G439-G444.